Tivic reports third quarter 2024 financial results and provides business update

Fremont, calif.--(business wire)--tivic health® systems, inc. (nasdaq: tivc), a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-months ended september, 30, 2024 financial results and discussed growth strategies based on its novel, patent-pending vagus nerve stimulation (vns) science and device technology. “this quarter we made significant progress on each of the three prongs of our strategy for delivering shareholder value," st.
TIVC Ratings Summary
TIVC Quant Ranking